These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34948317)

  • 1. Human Glucose Transporters in Renal Glucose Homeostasis.
    Sędzikowska A; Szablewski L
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of glucose transporters in renal diseases.
    Szablewski L
    J Biomed Sci; 2017 Aug; 24(1):64. PubMed ID: 28854935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saving the sweetness: renal glucose handling in health and disease.
    Shepard BD; Pluznick JL
    Am J Physiol Renal Physiol; 2017 Jul; 313(1):F55-F61. PubMed ID: 28356283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice.
    Sala-Rabanal M; Hirayama BA; Ghezzi C; Liu J; Huang SC; Kepe V; Koepsell H; Yu A; Powell DR; Thorens B; Wright EM; Barrio JR
    J Physiol; 2016 Aug; 594(15):4425-38. PubMed ID: 27018980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters.
    Deng D; Yan N
    Protein Sci; 2016 Mar; 25(3):546-58. PubMed ID: 26650681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Transport and Transporters in the Endomembranes.
    Lizák B; Szarka A; Kim Y; Choi KS; Németh CE; Marcolongo P; Benedetti A; Bánhegyi G; Margittai É
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic modeling for the effect of sodium-glucose cotransporter inhibitors on blood glucose level and renal glucose excretion in db/db mice.
    Yamaguchi K; Kato M; Ozawa K; Kawai T; Yata T; Aso Y; Ishigai M; Ikeda S
    J Pharm Sci; 2012 Nov; 101(11):4347-56. PubMed ID: 22927193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Products as Lead Compounds for Sodium Glucose Cotransporter (SGLT) Inhibitors.
    Blaschek W
    Planta Med; 2017 Aug; 83(12-13):985-993. PubMed ID: 28395363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside.
    Mudaliar S; Polidori D; Zambrowicz B; Henry RR
    Diabetes Care; 2015 Dec; 38(12):2344-53. PubMed ID: 26604280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of glucose transporters in human metabolic regulation].
    Magier Z; Jarzyna R
    Postepy Biochem; 2013; 59(1):70-82. PubMed ID: 23821945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the transcellular transport of FDG and D-glucose by the kidney epithelial cell line, LLC-PK1.
    Kobayashi M; Shikano N; Nishii R; Kiyono Y; Araki H; Nishi K; Oh M; Okudaira H; Ogura M; Yoshimoto M; Okazawa H; Fujibayashi Y; Kawai K
    Nucl Med Commun; 2010 Feb; 31(2):141-6. PubMed ID: 19949354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications.
    Kobayashi M; Uematsu T; Tokura Y; Takei K; Sakamoto K; Narimatsu T; Nukui A; Kamai T
    Int Braz J Urol; 2019; 45(1):169-178. PubMed ID: 30521176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active sugar transport in health and disease.
    Wright EM; Hirayama BA; Loo DF
    J Intern Med; 2007 Jan; 261(1):32-43. PubMed ID: 17222166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the kidneys in glucose homeostasis. Implication of sodium-glucose cotransporter 2 (SGLT2) in diabetes mellitus treatment].
    Girard J
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S35-S41. PubMed ID: 28577741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium-dependent glucose transporter protein as a potential therapeutic target for improving glycemic control in diabetes.
    Castaneda-Sceppa C; Castaneda F
    Nutr Rev; 2011 Dec; 69(12):720-9. PubMed ID: 22133196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-glucose cotransport.
    Poulsen SB; Fenton RA; Rieg T
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):463-9. PubMed ID: 26125647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitative glucose transport proteins and sodium-glucose co-transporters in the kidney.
    Hoffman BB; Ziyadeh FN
    Curr Opin Nephrol Hypertens; 1995 Sep; 4(5):406-11. PubMed ID: 8564443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.
    Wilding JP
    Metabolism; 2014 Oct; 63(10):1228-37. PubMed ID: 25104103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT inhibitors in management of diabetes.
    Tahrani AA; Barnett AH; Bailey CJ
    Lancet Diabetes Endocrinol; 2013 Oct; 1(2):140-51. PubMed ID: 24622320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in the gene expression profiles of glucose transporter GLUT class I and SGLT in mouse tissues.
    Nagai K; Yoshida S; Konishi H
    Pharmazie; 2014 Nov; 69(11):856-9. PubMed ID: 25985584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.